483
GE Healthcare Inc. - Life SciencesFDA 483 - GE Healthcare Inc. - Life Sciences - March 08, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of GE Healthcare Inc. - Life Sciences in Marlborough, MA, identified a significant issue related to the conduct of a clinical investigation. The firm failed to ensure that a study was carried out according to its general investigational plan and protocols. Specifically, data from subjects with uninterpretable image quality were improperly included in the Intent to Treat analysis, compromising the study's integrity.
Open in Dashboard
ID · 12ab724a-fff6-47f9-b5e2-58b34c7adf59